Back to ABUS
VERUS CAPITAL PARTNERS, LLC → ABUS
VERUS CAPITAL PARTNERS, LLC ABUS Position History
Arbutus Biopharma Corporation • Healthcare
Quarters held
12
Latest value
$73K
Q3 2026
Peak value
$128K
First seen
Q2 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2024 | $128K |
| Q3 2024 | $104K |
| Q4 2024 | $63K |
| Q1 2025 | $59K |
| Q2 2025 | $51K |
| Q3 2025 | $76K |
| Q3 2025 | $76K |
| Q4 2025 | $80K |
| Q4 2025 | $80K |
| Q1 2026 | $69K |
| Q2 2026 | $73K |
| Q3 2026 | $73K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $73K | 15.3K | — | — |
| Q2 2026 | $73K | 15.3K | — | — |
| Q1 2026 | $69K | 15.3K | — | — |
| Q4 2025 | $80K | 16.6K | — | — |
| Q4 2025 | $80K | 16.6K | — | — |
| Q3 2025 | $76K | 16.6K | — | — |
| Q3 2025 | $76K | 16.6K | — | — |
| Q2 2025 | $51K | 16.6K | — | — |
| Q1 2025 | $59K | 16.8K | — | — |
| Q4 2024 | $63K | 19.4K | — | — |
| Q3 2024 | $104K | 26.9K | — | — |
| Q2 2024 | $128K | 41.5K | — | — |
Other funds holding ABUS
$119.1M
$119.1M
$109.8M
$103.4M
$103.4M
$91.7M
$83.5M